Gastro Health First in U.S. to Utilize New Endoscopic Gastroscope

Dr. Daniel Gelrud performs first case using EUS J10 Series Video Gastroscope Miami based Gastro Health, a national leading medical group specializing in digestive health, is the first institution in the United States to utilize the latest diagnostic and therapeutic endoscopy technology, the J10 Series Ultrasound Video Gastroscope. Daniel Gelrud, MD, FACP, gastroenterologist and advanced endoscopist with Gastro Health, became the first physician to utilize the technology to examine a tumor in the wall of the patient’s stomach. “My first case with the EUS-J10 happened to be one where this technology really made a difference,” said Dr. Gelrud. “This patient had a tumor in the fundus of the...

read more

Aventura Hospital and Medical Center Appoints New COO

Aventura Hospital and Medical Center has named David Was, MBA, to the Chief Operating Officer (COO) role. In this position, David will be responsible for the oversight of surgical services, emergency services, ancillary and support services, construction and expansion, and the facility’s service line growth and development. David has been employed by HCA Healthcare for more than fifteen years, starting in HCA Healthcare’s Corporate Office in Nashville, TN, in 2005 and then joining HCA Healthcare’s Executive Development Program in 2010. He served as Associate Chief Operating Officer at Grand Strand Regional Medical Center in Myrtle Beach, SC, from 2010-2012 and then as Associate Chief...

read more

Featured Video

Home Health Acquisitions On the Run

Home health agencies everywhere have become the favorite targeted acquisitions of “the financial world.” Apparently, there is one seminar that every buyer attended convincing buyers or all kinds (buyers with money, buyers without money, buyers in the private equity space) that: HHAs are ripe for aggregation because the industry is disaggregated; and HHA owners lack business sophistication necessary to bring their businesses to the “next level.” Unfortunately, some of the buyers lack any true industry experience and are looking at acquisition targets solely from a financial perspective. They’re looking principally at business financials and nothing else. And, worse yet, they’re not focused...

read more


It’s Not Just Insulin: Lawmakers Focus on Price of One Drug, While Others Rise Too

Michael Costanzo, a Colorado farmer diagnosed with multiple sclerosis in 2016, has a well-honed ritual: Every six months, he takes an IV infusion of a medicine, Rituxan, to manage his disease, which has no cure. Then he figures out how to manage the bill, which costs thousands of dollars. For a time, the routine held steady: The price billed to his health insurance for one infusion would cost $6,201 to $6,841. Costanzo’s health insurance covered most of it, and he paid the rest out-of-pocket. But last fall the cost for the same 20-year-old drug and dosage jumped to $10,320, even though he was covered by the same insurance. “Why does it have to increase in price all of a sudden?” wondered...

read more